Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.6
4.0
Journals
Catalysts
Announcements
share announcement

Announcements

25 August 2025
Dr. Anthony S. Zannas Appointed Section Editor-in-Chief of Section “Molecular Biomarkers” in Biomolecules


We are pleased to announce that Dr. Anthony S. Zannas has been appointed Section Editor-in-Chief of the Section “Molecular Biomarkers” in Biomolecules (ISSN: 2218-273X).

The Section “Molecular Biomarkers”, part of MDPI’s open access journal Biomolecules publishes papers in all areas related to molecular biomarker research. This includes the identification, validation, and application of biomarkers in innovative diagnostic procedures, drug discovery/development, and disease pathogenesis.

We seek review and original research articles that address, but are not limited to, the following topics:

  • Predictive biomarkers;
  • Diagnostic biomarkers;
  • Prognostic biomarkers;
  • Pharmacokinetic and pharmacodynamic biomarkers;
  • Optimum biomarker selection and validation;
  • Biomarker development in omics;
  • Biomarker development in molecular medicine.

Dr. Anthony S. Zannas is an Associate Professor and Co-Director of the Carolina Stress Initiative at the Departments of Psychiatry and Genetics, the University of North Carolina. His research interests pertain to epigenetic and other molecular mechanisms linking environmental stress with accelerated aging and disease risk.

The following is a short Q&A with Dr. Anthony S. Zannas, who has shared his vision for the journal with us, as well as his views on the research area and open access publishing:

1. What appealed to you about the journal that made you want to become its Section Editor-in-Chief?

Biomolecules, and MDPI journals more generally, provide an accessible and efficient way of disseminating quality research.

2. What is your vision for this Section?

It covers a critical and timely area of research. Molecular biomarkers are a key tool for the future of biomedical science.

3. What does the future of this field of research look like?

Many of us envision a day when we will have highly reliable biomarkers to apply precision medicine, such as predicting individuals who will develop distinct disease outcomes or those who will respond to specific treatments. Despite many technological advancements, however, there is still a lot of work that needs to be done to materialize this vision.

4. Do you have any suggestions for young researchers in this field?

I always encourage young investigators to persevere and pursue their dreams. Good research takes time, and I believe that perseverance through failures and frustrations is the most important quality of a successful researcher.

5. What do you think of the development of open access in the publishing field?

While there are pros and cons, open access is currently a widespread trend in the field of publication. We can continue working together to support peer-reviewed research that serves the scientific community.

We welcome Dr. Anthony S. Zannas as the Section Editor-in-Chief for “Molecular Biomarkers”, and we look forward to achieving many more milestones under his guidance.

More News...
Back to TopTop